Pharmacist's Letter Canada | Convenient Monthly Updates + CE

Current Issue

January 2026 Issue

Address New GLP-1 Agonist Side Effect Concerns

Patients are asking if recent side effect claims with GLP-1 agonists (semaglutide, etc) are true...

Resources

Chart: GLP-1 and GIP/GLP-1 Receptor Agonist Interactive Comparison Chart
Chart: Treatment and Prevention of Hair Loss
FAQ: Managing Erectile Dysfunction
Chart: Perioperative Management of Diabetes

Be Familiar With the Laundry List of Uses for Dupilumab

New approved indications for dupilumab (Dupixent) SC injection will spur questions about when to recommend it...

Be Aware of the Role of Jornay PM for ADHD

Caregivers will ask you about Jornay PM, a new long-acting methylphenidate given in the EVENING...

Weave AI Into Your Plan for Precepting Learners

Preceptors are asking for advice on how to use artificial intelligence (AI) during learning experiences with residents and students...

GO TO FULL ISSUE

CE & Training

INTERACTIVE SELF-STUDY CE: Natural Medicines for Management of Type 2 Diabetes

CE-IN-THE-LETTER: Pharmacist's Letter Canada January 2026

LIVE CE: Pharmacy Essential Updates January 2026

PODCAST CE: Rumor vs Truth - GLP-1 Side Effects

GO TO CE & TRAINING ORGANIZER >

Featured Clinical Resources

GLP-1 and GIP/GLP-1 Receptor Agonists interactive chart

Group Purchases & Pricing

Pharmacist’s Letter Canada is eligible for bulk discounts. Easily manage staff access and customize CE & training assignments. Bundle with other products for significant savings. Request information